Prise en charge chirurgicale de l’adénocarcinome gastrique. Recommandations formalisées d’experts sous l’égide de l’Association française de chirurgie (AFC)

GLOBOCAN Cancer data. The Global Cancer Observatory 2018. Available from: http://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf. Chapelle, 2016, Erratum to: Trends in gastric cancer incidence: a period and birth cohort analysis in a well-defined French population, Gastric Cancer, 19, 682, 10.1007/s10120-015-0548-2 Grading quality of evidence and strength of recommendations. - PubMed - NCBI. https://www.ncbi.nlm.nih.gov/pubmed/15205295. Accessed February 12, 2020. Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD Kawanaka, 2016, Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: comparison with contrast-enhanced MDCT, Eur J Radiol, 85, 989, 10.1016/j.ejrad.2016.03.003 Kim, 2011, The value of PET/CT for preoperative staging of advanced gastric cancer: comparison with contrast-enhanced CT, Eur J Radiol, 79, 183, 10.1016/j.ejrad.2010.02.005 Yang, 2008, Is PET-CT suitable for predicting lymph node status for gastric cancer?, Hepatogastroenterology, 55, 782 Smyth, 2012, A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer, Cancer, 118, 5481, 10.1002/cncr.27550 Zaanan, 2018, Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO), Dig Liver Dis, 50, 768, 10.1016/j.dld.2018.04.025 Ott, 2008, Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study, Clin Cancer Res, 14, 2012, 10.1158/1078-0432.CCR-07-0934 Mocellin, 2015, Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer, Cochrane Database Syst Rev, CD009944 Andriulli, 1990, Endoscopic ultrasonographic evaluation of patients with biopsy negative gastric linitis plastica, Gastrointest Endosc, 36, 611, 10.1016/S0016-5107(90)71180-7 West, 2015, Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study, Br J Anaesth, 114, 244, 10.1093/bja/aeu318 Hughes, 2019, Prehabilitation before major abdominal surgery: a systematic review and meta-analysis, World J Surg, 43, 1661, 10.1007/s00268-019-04950-y Bolger, 2019, Perioperative prehabilitation and rehabilitation in esophagogastric malignancies: a systematic review, Dis Esophagus, 32, 10.1093/dote/doz058 Yamamoto, 2017, Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer, Gastric Cancer, 20, 913, 10.1007/s10120-016-0683-4 Cho, 2014, Matched pair analysis to examine the effects of a planned preoperative exercise program in early gastric cancer patients with metabolic syndrome to reduce operative risk: the Adjuvant Exercise for General Elective Surgery (AEGES) study group, Ann Surg Oncol, 21, 2044, 10.1245/s10434-013-3394-7 Sarela, 2006, Selection of patients with gastric adenocarcinoma for laparoscopic staging, Am J Surg, 191, 134, 10.1016/j.amjsurg.2005.10.015 Ramos, 2016, Staging laparoscopy in gastric cancer to detect peritoneal metastases: A systematic review and meta-analysis, Eur J Surg Oncol, 42, 1315, 10.1016/j.ejso.2016.06.401 Simon, 2016, Accuracy of staging laparoscopy in detecting peritoneal dissemination in patients with gastroesophageal adenocarcinoma, Dis Esophagus, 29, 236, 10.1111/dote.12332 Japanese Gastric Cancer Association null, 1998, Japanese Classification of Gastric Carcinoma - 2nd English Edition, Gastric Cancer, 1, 10, 10.1007/PL00011681 Bentrem, 2005, The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection, Ann Surg Oncol, 12, 347, 10.1245/ASO.2005.03.065 Miyashiro, 2005, When is curative gastrectomy justified for gastric cancer with positive peritoneal lavage cytology but negative macroscopic peritoneal implant?, World J Surg, 29, 1131, 10.1007/s00268-005-7703-6 Badgwell, 2008, Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival?, Ann Surg Oncol, 15, 2684, 10.1245/s10434-008-0055-3 Conlon, 2001, Staging laparoscopy for gastric cancer, Ann Ital Chir, 72, 33 Bonenkamp, 1996, Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer, Br J Surg, 83, 672, 10.1002/bjs.1800830526 Bower, 2009, Nutritional management during neoadjuvant therapy for esophageal cancer, J Surg Oncol, 100, 82, 10.1002/jso.21289 Nozoe, 2002, Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma, Eur J Surg Oncol, 28, 396, 10.1053/ejso.2002.1257 Daly, 1979, Evaluation of nutritional indices as prognostic indicators in the cancer patient, Cancer, 43, 925, 10.1002/1097-0142(197903)43:3<925::AID-CNCR2820430321>3.0.CO;2-5 Nourissat, 2008, Relationship between nutritional status and quality of life in patients with cancer, Eur J Cancer, 44, 1238, 10.1016/j.ejca.2008.04.006 Weijs, 2015, Routes for early enteral nutrition after esophagectomy. A systematic review, Clin Nutr, 34, 1, 10.1016/j.clnu.2014.07.011 Huddy, 2018, Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer-a narrative review, Dis Esophagus, 31, 1, 10.1093/dote/dox110 Manfredelli, 2017, Could a feeding jejunostomy be integrated into a standardized preoperative management of oeso-gastric junction adenocarcinoma?, Ann Surg Oncol, 24, 3324, 10.1245/s10434-017-5945-9 Park, 2012, Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective study, Surg Endosc, 26, 1548, 10.1007/s00464-011-2065-7 Kinoshita, 2019, Long-term outcomes of laparoscopic versus open surgery for clinical stage II/III gastric cancer: a multicenter cohort study in Japan (LOC-A Study), Ann Surg, 269, 887, 10.1097/SLA.0000000000002768 Shinohara, 2013, Laparoscopic versus open D2 gastrectomy for advanced gastric cancer: a retrospective cohort study, Surg Endosc, 27, 286, 10.1007/s00464-012-2442-x Cai, 2011, A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer, Dig Surg, 28, 331, 10.1159/000330782 Park, 2018, Laparoscopy-assisted versus open D2 distal gastrectomy for advanced gastric cancer: results from a randomized phase II multicenter clinical trial (COACT 1001), Ann Surg, 267, 638, 10.1097/SLA.0000000000002168 Lee, 2019, Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy with D2 lymphadenectomy to open distal gastrectomy for locally advanced gastric cancer (KLASS-02-RCT), Ann Surg, 270, 983, 10.1097/SLA.0000000000003217 Yu, 2019, Effect of laparoscopic vs. open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial, JAMA, 321, 1983, 10.1001/jama.2019.5359 Haverkamp, 2015, Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial), BMC Cancer, 15, 556, 10.1186/s12885-015-1551-z Straatman, 2015, Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): study protocol for a randomized controlled trial, Trials, 16, 123, 10.1186/s13063-015-0638-9 Liedman, 1997, Changes in body composition after gastrectomy: results of a controlled, prospective clinical trial, World J Surg, 21, 416, 10.1007/PL00012264 Gertler, 2009, Pouch vs. no pouch following total gastrectomy: meta-analysis and systematic review, Am J Gastroenterol, 104, 2838, 10.1038/ajg.2009.456 Syn, 2019, Pouch versus no pouch following total gastrectomy: meta-analysis of randomized and non-randomized studies, Ann Surg, 269, 1041, 10.1097/SLA.0000000000003082 Fujimoto, 1988, Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding, Ann Surg, 208, 36, 10.1097/00000658-198807000-00005 Sadeghi, 2000, Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study, Cancer, 88, 358, 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O Glehen, 2010, Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy, Ann Surg Oncol, 17, 2370, 10.1245/s10434-010-1039-7 Chia, 2016, Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility?, Ann Surg Oncol, 23, 1971, 10.1245/s10434-015-5081-3 Coccolini, 2015, Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis, Eur J Surg Oncol, 41, 911, 10.1016/j.ejso.2015.03.231 Liu, 2019, Effect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of the randomized controlled trials, J Int Med Res, 47, 5926, 10.1177/0300060519882545 Bonnot, 2019, Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis, J Clin Oncol, 37, 2028, 10.1200/JCO.18.01688 Glehen, 2014, GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study, BMC Cancer, 14, 183, 10.1186/1471-2407-14-183 Wagner, 2017, Chemotherapy for advanced gastric cancer, Cochrane Database Syst Rev, 8, CD004064 Van Cutsem, 2006, Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group, J Clin Oncol, 24, 4991, 10.1200/JCO.2006.06.8429 Guimbaud, 2014, J Clin Oncol, 32, 3520, 10.1200/JCO.2013.54.1011 Roth, 2007, Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research, J Clin Oncol, 25, 3217, 10.1200/JCO.2006.08.0135 Alyami, 2019, Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications, Lancet Oncol, 20, e368, 10.1016/S1470-2045(19)30318-3 Ikeda, 2009, Gastric cancer surgery for patients with liver cirrhosis, World J Gastrointest Surg, 1, 49, 10.4240/wjgs.v1.i1.49 Lee, 2005, Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection, World J Gastroenterol, 11, 4623, 10.3748/wjg.v11.i30.4623 Jang, 2008, Clinical outcomes of patients with liver cirrhosis who underwent curative surgery for gastric cancer: a retrospective multi-center study, Dig Dis Sci, 53, 399, 10.1007/s10620-007-9884-3 Guo, 2014, Surgical strategy for gastric cancer patients with liver cirrhosis: a retrospective cohort study, Int J Surg, 12, 810, 10.1016/j.ijsu.2014.06.011 Jeong, 2010, Increased morbidity rates in patients with heart disease or chronic liver disease following radical gastric surgery, J Surg Oncol, 101, 200, 10.1002/jso.21467 Boyer, 2010, American Association for the Study of Liver Diseases. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009, Hepatology, 51, 306, 10.1002/hep.23383 Becq, 2015, Transjugular intrahepatic portosystemic shunt as bridge-to-surgery in refractory gastric antral vascular ectasia, World J Gastroenterol, 21, 5749, 10.3748/wjg.v21.i18.5749 Fujitani, 2016, Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial, Lancet Oncol, 17, 309, 10.1016/S1470-2045(15)00553-7 Tey, 2014, Clinical outcome of palliative radiotherapy for locally advanced symptomatic gastric cancer in the modern era, Medicine, 93, e118, 10.1097/MD.0000000000000118 Upchurch, 2018, Stent placement versus surgical palliation for adults with malignant gastric outlet obstruction. Cochrane Upper GI and Pancreatic Diseases Group, ed., Cochrane Datab Syst Rev, 10.1002/14651858.CD012506.pub2 Omori, 2019, Role of palliative resection in patients with incurable advanced gastric cancer who are unfit for chemotherapy, World J Surg, 43, 571, 10.1007/s00268-018-4816-2 the FREGAT Working Group, 2013, Palliative resection for advanced gastric and junctional adenocarcinoma: which patients will benefit from surgery?, Ann Surg Oncol, 20, 1240, 10.1245/s10434-012-2687-6